Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Trevi Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +9 vs. Q1 2022
- Shares held
- 28.8M
- +21.6M (+301.3%) vs. Q1 2022
- Total value
- $80.8M
- +$47.9M (+145.6%) vs. Q1 2022
- New holders
- 13
- 12 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 166 | $0 | 0.00% | +93+127.4% | Added |
| Curi Capital | 998 | $3.00K | 0.00% | −3,746−79.0% | Reduced |
| Citigroup Inc | 1,700 | $5.00K | 0.00% | +1,700 | New |
| First Manhattan Co | 2,500 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,874 | $11.0K | 0.00% | −5,603−59.1% | Reduced |
| UBS Group AG | 4,771 | $13.0K | 0.00% | +3,147+193.8% | Added |
| FNY Investment Advisers, LLC | 7,986 | $22.0K | 0.02% | +7,986 | New |
| LPL Financial LLC | 10,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 12,557 | $36.0K | 0.00% | +12,557 | New |
| United Bank | 28,450 | $80.0K | 0.01% | +1,750+6.6% | Added |
| Acuta Capital Partners, LLC | 35,000 | $98.0K | 0.05% | +35,000 | New |
| State Street Corp | 39,842 | $112.0K | 0.00% | +3,000+8.1% | Added |
| Northern Trust Corp | 46,298 | $130.0K | 0.00% | +34,884+305.6% | Added |
| BlackRock Inc. | 57,494 | $161.0K | 0.00% | +24,055+71.9% | Added |
| Millennium Management LLC | 66,183 | $186.0K | 0.00% | −18,697−22.0% | Reduced |
| FMR LLC | 83,225 | $234.0K | 0.00% | +83,225 | New |
| WealthTrust Axiom LLC | 93,500 | $262.0K | 0.09% | −5,000−5.1% | Reduced |
| Bridgeway Capital Management, LLC | 102,600 | $288.0K | 0.01% | +27,600+36.8% | Added |
| J. Goldman & Co LP | 135,000 | $379.0K | 0.03% | +135,000 | New |
| Renaissance Technologies LLC | 151,500 | $426.0K | 0.00% | +35,500+30.6% | Added |
| Geode Capital Management, LLC | 195,146 | $548.0K | 0.00% | +122,402+168.3% | Added |
| Vanguard Group Inc | 236,940 | $666.0K | 0.00% | +84,109+55.0% | Added |
| EAM Investors, LLC | 373,243 | $1.05M | 0.26% | +373,243 | New |
| Armistice Capital, LLC | 416,000 | $1.17M | 0.03% | +416,000 | New |
| Frazier Life Sciences Management, L.P. | 1,171,627 | $3.29M | 0.31% | +1,171,627 | New |
| Altium Capital Management LP | 1,284,000 | $3.61M | 1.53% | +1,284,000 | New |
| Fairmount Funds Management LLC | 1,624,389 | $4.57M | 1.04% | +1,624,389 | New |
| Rubric Capital Management LP | 1,778,420 | $5.00M | 0.26% | +1,778,420 | New |
| MAI Capital Management | 2,040,009 | $5.73M | 0.11% | +498,538+32.3% | Added |
| VR Adviser, LLC | 3,050,022 | $8.57M | 1.69% | +3,050,022 | New |
| TPG GP A, LLC | 4,324,883 | $12.2M | 0.19% | −500,000−10.4% | Reduced |
| NEA Management Company, LLC | 11,373,174 | $32.0M | 1.64% | +11,370,376+406,375.1% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −23,402−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,055−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −589−100.0% | Sold out |